Nussbaum Rodney L bought GYRE
March 20, 2024 · Form 4 insider transaction
Nussbaum Rodney L bought 1,866 shares of Gyre Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
1,866
Price
$0.00
Total value
N/A
InsiderNussbaum Rodney L
RoleDirector
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateMarch 20, 2024
Filing dateMarch 21, 2024
Shares owned after1,866
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
These options vest as to one-third on each of the first, second and third anniversaries of the grant date, subject to the Reporting Person's continued service to the Issuer through each vesting date.